Cardiopulmonary Exercise Testing Market Increased prevalence of cardiac disorders has led to a gradual rise in cardiopulmonary exercise testing. In 2017, the global market for cardiopulmonary exercise testing was valued at USD 2248.21 Mn.
Market Scenario
Cardiopulmonary exercise testing is an effective way of analyzing heart condition and cardiopulmonary attributes. The test procedure includes electrocardiography analysis, blood pressure, etc. Such tests are extremely common in advanced countries owing to the high level of awareness among people along with rising health consciousness.
This characterizes the exponential growth of cardiopulmonary exercise testing in North America. The cardiopulmonary exercise testing market in the region is poised to grow at a compound annual Growth Rate Of 5.75% Between 2018 And 2023.
Free Sample at https://www.marketresearchfuture.com/sample_request/6626
Key Players:
The report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report.
- GE Healthcare
- Cardinal Health
- Halma plc.
- Koninklijke Philips N.V.
- COSMED srl
- Masimo Corporation
- Hill-Rom Holdings Inc.
- MGC Diagnostics Corporation
- NIHON KOHDEN CORPORATION
- Schiller AG and Vyaire Medical Inc
Segmentation
MRFR’s report includes a comprehensive segmental analysis of the market based on products and end-user.
On the basis of product, the market has been segmented into Cardiopulmonary exercise testing (CPET) systems, echocardiogram, pulse oximeters, stress blood pressure monitors, single-photon emission computed tomography (SPECT), and others.
On the basis of end-user, the global Cardiopulmonary exercise testing market is segmented into hospitals and clinics, diagnostic centers, ambulatory centers, and others.
The segment is projected to reach a market valuation of over USD 1100 Mn by the year 2023, reflecting an impressive growth rate. Growing need for diagnosis and treatment of heart diseases and coronary diseases is supporting the growth of the segment.
Brows Complete Premium Research Report@ https://www.marketresearchfuture.com/reports/Cardiopulmonary-exercise-testing-market-6626
Regional Analysis
The market has been covered across major regions such as Europe, North America, South America, the Middle East & Africa (MEA) and Asia Pacific (APAC).
North America and South America collectively accounted for the largest market in 2017 and the trend is likely to continue in 2018 and beyond. Presence of a large patient population and availability of cutting-edge medical technology put the Americas, in particular North America at an advantageous position in the global Cardiopulmonary exercise testing market. In addition, widespread awareness about advantages of early diagnostics is creating growth opportunities for market in North America.
Meanwhile, Europe represent the second largest market for Cardiopulmonary exercise testing. Factors such as high healthcare expenditure and availability of medical welfare schemes are having positive impact on the regions market.
Intended Audience
- Cardiopulmonary Resuscitation Manufacturing Companies
- Medical Devices Components Manufacturing Companies
- R & D laboratories
- Suppliers and Distributors of the medical devices
- Potential Investors
Inquire for Exclusive Discount@ https://www.marketresearchfuture.com/check-discount/6626
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312
Your information will never be shared with any third party.